Official Journal of Research Center for Gastroenterology and Liver Diseases
Authors
3, Chiara Rosso1, Antonella Olivero1, Rinaldo Pellicano3,*, Giovanni Antonio Touscoz3, Antonina Smedile3, Mario Rizzetto3Occult hepatitis B virus infection (OBI) is defined as the presence of hepatitis B virus (HBV) DNA in the liver and/or in the serum of patients with negative results of hepatitis B s antigen (HBsAg) test with or without serological markers of previous viral exposure. The impact of OBI in patients with chronic hepatitis C (CHC) is still unclear.
The Aim of this study was to assess OBI prevalence and its potential implications on treatment outcome in a cohort of patients with CHC underwent standard antiviral therapy.
Baseline serum samples from 137 HBsAg-negative CHC patients treated with pegylated-interferon and ribavirin (73 Responders/74 Non Responders),were retrospectively analyzed for HBV status.
Seventy-three patients (53.3%) showed markers of previous exposure to HBV. HBV DNA was detected in 2 of 137 serum samples (1.5%), both carrying HBV antibodies. Liver biopsies and post-therapy sera were available for 35 patients (12 Responders/23 Non Responders). HBV DNA sequences were found in 13 of 35 specimens (37.1%), all of patients with HBV DNA negativity in basal and post-therapy serum samples. Among OBI-positive patients, 5 (38.5%) carried serological markers of HBV infection. Regarding therapy outcome, in the OBI-positive group there were 5 of 13 (38.5%) sustained virological responders (SVR) compared to 7 of 22 (31.8%) in the OBI-negative one.
Despite the high prevalence rate of liver HBV DNA in patients with CHC, SVR was not affected by occult HBV infection.
© 2012, Author(s). This open-access article is available under the Creative Commons Attribution 4.0 (CC BY 4.0) International License (https://creativecommons.org/licenses/by/4.0/), which allows for unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited.
Aghazadeh R, Honarkar , Alavian S, Samiee S, Saeedfar K, et al. Occult HBV Infection among Chronic Hepatitis C Patients. Shiraz E-Med J. 2006;7(2):20372. doi:
de Almeida NAA, Barros JJ, de Santana CG, Spitz N, Campos LB, et al. Evaluation of Occult Hepatitis B Infection in Individuals with Chronic Hepatitis C Before Treatment with Oral Direct-Acting Antivirals. Hepat Mon. 2019;19(12):e92317. doi: https://doi.org/10.5812/hepatmon.92317
Vakili Ghartavol Z, Alavian SM, Amini S, Vahabpour R, Bahramali G, et al. Prevalence of Occult Hepatitis B Virus in Plasma and Peripheral Blood Mononuclear Cell Compartments of Patients With Chronic Hepatitis C Infection in Tehran-Iran. Hepat Mon. 2013;13(5):e10134. doi: https://doi.org/10.5812/hepatmon.10134
Erol S, Ozkurt Z, Ozbek A, Parlak M. Poor Response to Treatment with Peg-IFN Containing Regimens in Patients Coinfected with Hepatitis B and Hepatitis C Virus. Hepat Mon. 2009;9(3):. doi:
Makvandi M, Neisi N, Khalafkhany D, Makvandi K, Hajiani E, et al. Occult Hepatitis B Virus Among the Patients With Abnormal Alanine Transaminase. Jundishapur J Microbiol. 2014;7(8):e11648. doi: https://doi.org/10.5812/jjm.11648
More by these authors
Last Update: 1 month ago
Last Update: 1 month ago
Last Update: 1 month ago
Last Update: 4 days ago